These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 222019)

  • 1. Treatment of life-threatening infections in renal transplant recipients with high-dose intravenous human IgG.
    Condie RM; Hall BL; Howard RJ; Fryd D; Simmons RL; Najarian JS
    Transplant Proc; 1979 Mar; 11(1):66-8. PubMed ID: 222019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polyvalent immune globulin and cytomegalovirus infection after renal transplantation.
    Kasiske BL; Heim-Duthoy KL; Tortorice KL; Ney AL; Odland MD; Rao KV
    Arch Intern Med; 1989 Dec; 149(12):2733-6. PubMed ID: 2556978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidence and prognostic value of cytomegalovirus-specific antibodies of the IgM class in kidney transplant recipients].
    Eichler C; Kaden J; May G
    Z Urol Nephrol; 1990 Aug; 83(8):425-9. PubMed ID: 2173294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients?
    Khawand N; Light JA; Brems W; Aquino A; Ali A
    Transplant Proc; 1989 Feb; 21(1 Pt 2):2072-4. PubMed ID: 2540555
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperimmune immunoglobulin therapy for cytomegalovirus infections in renal transplant patients.
    Brown CB; Nicholls AJ; Edward N; Cuthbertson B; Yap PL; McClelland DB
    Proc Eur Dial Transplant Assoc; 1983; 20():271-9. PubMed ID: 6318221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG.
    Dreikorn K; Doerr HW; Geursen RG
    Scand J Urol Nephrol Suppl; 1985; 92():15-21. PubMed ID: 3008312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of the efficacy of cytomegalovirus immune globulin in the prophylaxis of CMV disease in renal transplant recipients.
    Snydman DR
    Transplant Proc; 1993 Oct; 25(5 Suppl 4):25-6. PubMed ID: 8212304
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients.
    Rand KH; Houck H; Ganju A; Babington RG; Elfenbein GJ
    Bone Marrow Transplant; 1989 Nov; 4(6):679-83. PubMed ID: 2555005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of high dose polyvalent intravenous immunoglobulin (HDIgG) vs. Cytomegalovirus (CMV) hyperimmune IgG in allogeneic hemopoietic stem cell transplants (HSCT).
    Zikos P; Van Lint MT; Lamparelli T; Gualandi F; Occhini D; Mordini N; Berisso G; Bregante S; Bacigalupo A
    Haematologica; 1998 Feb; 83(2):132-7. PubMed ID: 9549924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytomegalovirus (CMV) infection: a frequent and life-threatening complication in heart transplant patients].
    Mohacsi P; Leonardi L; Waser M; Lüthy A; Laske A; Turina M; Gallino A
    Ther Umsch; 1990 Feb; 47(2):157-63. PubMed ID: 2156344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and biological evaluation of the preventive role of anti-cytomegalovirus specific immunoglobulins in bone marrow grafts. Randomized study of 60 patients].
    Bordigoni P; Janot C; Aymard JP; Witz F; Bené MC; Legras B; Schoonemann F; Olive D; Streiff F
    Nouv Rev Fr Hematol (1978); 1987; 29(5):289-93. PubMed ID: 2830588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis of CMV infection in bone marrow transplant recipients by hyperimmune CMV gamma-globulin.
    Condie RM; O'Reilly RJ
    Dev Biol Stand; 1982; 52():501-13. PubMed ID: 6299859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Locally produced specific cytomegalovirus immunoglobulin for intramuscular use as a therapy in renal allograft recipients.
    Trkuljić M; Ignjatović L; Hrvacević R; Taseski J; Dujić A; Jovanović D; Kuljić-Kapulica N
    Vojnosanit Pregl; 2001; 58(2):131-6. PubMed ID: 11475664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum immunoglobulin concentrations in patients following bone marrow transplantation and preventive administration of high-dose nonspecific or normal-dose CMV-specific immunoglobulin].
    Berger C; Gratwohl A; Doran JE; Scherz R; Baumgartner C; Morell A; Bachmann B; Spaeth PJ; Tichelli A; Speck B
    Beitr Infusionsther; 1989; 24():112-21. PubMed ID: 2481528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular rejection of renal allografts is linked to CMV IgG, positive organ donor.
    Tenschert W; Dittmer R; Harfmann P; Cremaschi L; Meyer-Moldenhauer WH; Arndt R; Klosterhalfen H
    Transplant Proc; 1991 Oct; 23(5):2641-2. PubMed ID: 1656565
    [No Abstract]   [Full Text] [Related]  

  • 17. Increased IgM and IgM immune complex-like material in the circulation of renal transplant recipients with primary cytomegalovirus infections.
    Baldwin WM; van Es A; Valentijn RM; van Gemert GW; Daha MR; Vanes LA
    Clin Exp Immunol; 1982 Dec; 50(3):515-24. PubMed ID: 6299633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is gammaglobulin anti-CMV warranted in lung transplantation?
    García-Gallo CL; Gil PU; Laporta R; Carreño MC; de Pablo A; Ferreiro MJ
    Transplant Proc; 2005 Nov; 37(9):4043-5. PubMed ID: 16386622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of cytomegalovirus infection in bone marrow transplant recipients by prophylaxis with an intravenous, hyperimmune cytomegalovirus globulin.
    Condie RM; O'Reilly RJ
    Birth Defects Orig Artic Ser; 1984; 20(1):327-44. PubMed ID: 6329370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.